Literature DB >> 20495624

Molecular characterization of Vibrio cholerae outbreak strains with altered El Tor biotype from southern India.

A K Goel, M Jain, P Kumar, S C Jiang.   

Abstract

Forty-four Vibrio cholerae isolates collected over a 7-month period in Chennai, India in 2004 were characterized for gene traits, antimicrobial susceptibility and genomic fingerprints. All 44 isolates were identified as O1 El Tor Ogawa, positive for various toxigenic and pathogenic genes viz. ace, ctxB, hlyA, ompU, ompW, rfbO1, rtx, tcpA, toxR and zot. Nucleotide sequencing revealed the presence of cholera toxin B of classical biotype in all the El Tor isolates, suggesting infection of isolates by classical CTXPhi. Antibiogram analysis showed a broad-spectrum antibiotic resistance that was also confirmed by the presence of resistant genes in the genomes. All isolates contained a class 1 integron and an SXT constin. However, isolates were sensitive to chloramphenicol and tested negative for the chloramphenicol resistant gene suggesting a deletion in SXT constin. Fingerprinting analysis of isolates by ERIC- and Box PCR revealed similar DNA patterns indicating the clonal dissemination of a single predominant V. cholerae O1 strain throughout the 2004 outbreak in Chennai. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11274-009-0171-7) contains supplementary material, which is available to authorized users.

Entities:  

Year:  2009        PMID: 20495624      PMCID: PMC2872801          DOI: 10.1007/s11274-009-0171-7

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


Introduction

The disease cholera, caused by the bacteria Vibrio cholerae, is a continuous public health problem in countries with poor socio-economic conditions. Almost every developing country is facing either a cholera outbreak or the threat of an epidemic. Cholera has the potential to appear in explosive outbreak, epidemic or even pandemics. The world has already faced seven cholera pandemics in the past two centuries (Kaper et al. 1995). The Indian sub-continent has been an epicenter for cholera. Chennai, a metropolitan city in Southern India, is plagued by reoccurring cholera outbreaks in suburbs due to contamination of drinking water supplies. V. cholerae O139 strain, an epidemic strain that was unknown prior to 1991, emerged from this region and spread to the Southeast Asian countries. The two biotypes of O1 serotype, El Tor and classical are believed to have evolved from separate lineages (Kaper et al. 1995). Between the two biotypes, El Tor strains have better adaptability to survive in the environment and in the human host as they colonize better the intestinal epithelium (Finkelstein 2006). Strains of classical biotype are suggested to be more toxigenic than El Tor strains (Huq et al. 1993). Recent studies have shown the spread of El Tor strains harbouring classical cholera toxin gene in US Gulf Coast and several countries in Asia and Africa (Nair et al. 2006; Goel et al. 2008). In this study, we report molecular characterization of 44 V. cholerae O1 isolates from patients during a cholera outbreak in Chennai from April to November 2004. Strains were characterized for antimicrobial susceptibility, the presence of various toxigenic and pathogenic genes, nucleotide sequences of ctxB gene, and genomic fingerprints. This research contributes to our understanding of V. cholerae disease pattern and the evolution of pathogenicity.

Materials and methods

Bacterial cultures

The V. cholerae strains were isolated from stool samples of randomly selected patients during an outbreak in Chennai, India, between April and November 2004. Samples were collected using sterile rectal swabs from the patients admitted at Communicable Disease Hospital, Chennai as described earlier (Pourshafie et al. 2007). Forty-four isolates were randomly selected spanning the 7-month sampling period. V. cholerae was identified and confirmed by using standard biochemical methods (Tamrakar et al. 2006). Serological identification of the isolates was done by slide agglutination using commercially available polyvalent antiserum against V. cholerae O1 and O139 (Difco, USA). Biotype of isolates was confirmed by polymyxin B sensitivity and VP test. V. cholerae O1 (ATCC 11623) and V. cholerae O139 (ATCC 51394) were used as reference strains.

Biochemical characterization

All bacterial isolates were screened for oxidase reaction followed by other standard tests for presumptive identification of V. cholerae (Tamrakar et al. 2006). Serological identification of the isolates was done by slide agglutination using commercially available polyvalent antiserum against V. cholerae O1 and O139 (Difco, USA).

Antibiotic susceptibility

The antimicrobial susceptibility of the V. cholerae isolates was determined by the disc diffusion method on Mueller–Hinton agar as described by the Clinical Laboratory Standards Institute (CLSI 2007). The antibiotics discs were used at the following concentrations: ampicillin (10 μg), chloramphenicol (30 μg), ceftazidime (10 μg), ciprofloxacin (5 μg), co-trimoxazole (25 μg), gentamicin (10 μg), kanamycin (30 μg), nalidixic acid (30 μg), nitrofurantoin (300 μg), norfloxacin (10 μg), polymyxin-B (50 μg), spectinomycin (100 μg), streptomycin (10 μg), sulphamethizole (300 μg), sulphamethoxazole (100 μg) tetracycline (30 μg) and trimethoprim (5 μg). The antibiotic discs used in this study were purchased from HiMedia, India.

Detection of gene traits

Genomic DNA was extracted from each of the isolate using genomic DNA purification kit (MBI Fermentas, Vilnius, Lithuania) and screened for the presence of diverse gene traits by two sets of multiplex PCR as described elsewhere (Kumar et al. 2009). The first multiplex PCR revealed the presence of ompW, ctxB, rfbO1, tcp and zot genes. The second set of multiplex PCR detected rtxC, ace, hlyA, ompU and toxR gens. Primer sequences used for amplification of different genes are listed in Table 1. The specificity of PCR was confirmed by using reference bacterial strains. PCR amplification was carried out in a 25 μl reaction mixture using a Palm Cycler (Corbett Life Sciences, Australia). The reaction mixture contained 1× reaction buffer, 200 μM dNTPs, 1.5 mM MgCl2, 1 U of Taq polymerase (Fermentas), varying concentration of primers (see Table 1) specific for each target gene, 100 ng of template DNA and milli-Q water. The thermal cycling conditions for both the multiplex PCR were: pre-incubation at 94°C for 2 min, 30 cycles of 1 min at 94°C for denaturation, 1 min at 59°C for annealing and 2 min at 72°C for extension followed by incubation at 72°C for 10 min for final extension.
Table 1

PCR primers used in this study

PrimerNucleotide sequenceAmplicon size (bp)Primer used in 25 μl RXN (pmol)Annealing temperature (°C)References
ompW (F) GGTAGCCTTGGTGATATTGGTG2081259This study
ompW (R) TAGCAGCAAGTCCCCATGAGT12
ctxB (F) GCCGGGTTGTGGGAATGCTCCAAG536959Goel et al. (2007)
ctxB (R) CATGCGATTGCCGCAATTAGTATGGC9
rfbO1 (F) TCTATGTGCTGCGATTGGTG6381059Goel et al. (2007)
rfbO1 (R) CCCCGAAAACCTAATGTGAG10
tcp-F CGTTGGCGGTCAGTCTTG8051059Goel et al. (2007)
tcp-R CGGGCTTTCTTCTTGTTCG10
zot (F) TCGCTTAACGATGGCGCGTTTT947859Singh et al. (2001)
zot (R) AACCCCGTTTCACTTCTACCCA8
rtxC-F CGACGAAGATCATTGACGAC2651059Chow et al. (2001)
rtxC-R CATCGTCGTTATGTGGTTGC10
ace-FTAAGGATGTGCTTATGATGGACACCC3091059Kumar et al. (2009)
ace-R CGTGATGAATAAAGATACTCATAGG10
hlyA-F GAGCCGGCATTCATCTGAAT4801059Kumar et al. (2009)
hlyA-R CTCAGCGGGCTAATACGGTTTA10
toxr-F CCTTCGATCCCCTAAGCAATAC7791059Kumar et al. (2009)
toxr-R: AGGGTTAGCAACGATGCGTAAG10
ompU-F: ACGCTGACGGAATCAACCAAAG8691059Kumar et al. (2009)
ompU-R GCGGAAGTTTGGCTTGAAGTAG10
ctx-F GATACACATAATAGAATTAAGGATG4611059Olsvik et al. (1993)
ctx-R GGTTGCTTCTCA TCATCGAACCAC10
ERIC-F ATGTAAGCTCCTGGGGATTCACVariable1052Rivera et al. (1995)
ERIC-R AAGTAAGTGACTGGGTGAGCG
BOX A1R CTACGGCAAGGCGACGCTGACGVariable1053Versalovic et al. (1994)
qacEΔ1-F ATCGCAATAGTTGGCGAAGT8001058Dalsgaard et al. (2000)
Sul1-B GCAAGGCGGAAACCCGCC10
int1-F GCTGGATAGGTTAAGGGCGG5921055Hochhut et al. (2001)
int1-R CTCTATGGGCACTGTCCACATTG10
in-F GGCATCCAAGCAGCAAGC10Collis and Hall (1992)
aadA-R* ATTGCCCAGTCGGCAGCG6501055Kazama et al. (1995)
blaP1-R* CTGGTTCATTTCAGATAGCG8741052Kazama et al. (1995)
strA-F TTGATGTGGTGTCCCGCAATGC3831057Hochhut et al. (2001)
strA-R CCAATCGCAGATAGAAGGCAA10
floR-F TTATCTCCCTGTCGTTCCAGCG5261057Iwanaga et al. (2004)
floR-R CCTATGAGCACACGGGGAGC10

* Paired with in-F

PCR primers used in this study * Paired with in-F

PCR for class 1 integron and SXT constin genes

Class 1 integron was detected by PCR using primers qacEΔ1-F and sul1-B, directed at the 3′-CS of class 1 integrons. To investigate the presence of SXT constin, a conjugative self transmissible plasmid, primers int1-F and int1-B specific for SXT integrase were used (Hochhut et al. 2001). The primer sequences and PCR conditions used for class 1 integrons and SXT constin were identical to those described previously (Hochhut et al. 2001). To verify the presence of antibiotic resistant gene cassettes among integrons, primers in-F and aadA-B were used to detect the presence of aadA2 gene cassette encoding resistance to streptomycin and spectinomycin. Primers in-F and blaP1-B were used to detect the presence of β-lactam gene cassette in integrons (Dalsgaard et al. 2000). Isolates positive for SXT integrase gene were examined for the presence of the SXT-associated resistance genes, floR and strA (encoding for chloramphenicol and streptomycin resistance, respectively) by PCR as previously described (Hochhut et al. 2001).

Sequencing of cholera toxin (ctxB) gene

Cholera toxin B (ctxB) gene was amplified from the isolates using the ctxF and ctxR primers as described earlier (Olsvik et al. 1993). Sequencing was carried out using the same PCR primers on a 96 capillary model 3730xl system using the Big Dye Terminator kit from Applied Biosystems (Applied Biosystems, Foster City, CA, USA). The sequences were edited with SeqED program (Applied Biosystems), and were aligned with reference strains using ClustalW program. The sequences of ctxB gene for reference strains were retrieved from the public domain (GenBank).

Nucleotide sequence accession number

The nucleotide sequences obtained for the ctxB gene of strains VCC1588, VCC1969, VCC2411, VCC2491, VCC4372, VCC5910, VCC5963 and VCC5988 have been deposited in GenBank under accession number EU428013, EU428014, EU428015, EU428016, EU428017, EU428018, EU428019 and EU428020, respectively.

Genomic DNA fingerprinting analyses

Enterobacterial repetitive intergenic consensus (ERIC) sequence PCR was performed as described earlier with little modifications by using two oligonucleotides ERIC-F and ERIC-R (Rivera et al. 1995). The thermal cycler was programmed for 35 cycles of 1 min at 94°C, 1 min at 52°C, 10 min at 68°C followed by 20 min incubation at 70°C. BOX PCR was performed by using a single nucleotide primer BOX A1R (Versalovic et al. 1994). PCR program consisted of: initial denaturation (95°C for 7 min), 30 cycles of 94°C for 1 min, 53°C for 1 min, 65°C for 8 min, and a final extension of 65°C for 16 min.

Results and discussion

Strain identification and detection of gene traits

A total of 44 bacteria isolated from the patients were biochemically identified as V. cholerae and serologically confirmed as O1 Ogawa. Multiplex PCR analysis revealed that all strains tested positive for ace, ctxB, hlyA, ompU, ompW, rfbO1, rtx, tcpA, toxR and zot genes (Fig. 1). The outer membrane gene (ompW) is species specific for V. cholerae and its presence confirms the biochemical identification of V. cholerae. Somatic O-antigen biosynthesis gene was positive for O1 type (rfbO1), providing molecular evidence for O1 serogroup. Collectively, the results indicated that 2004 Chennai outbreak was caused by a toxigenic V. cholerae O1 Ogawa.
Fig. 1

Multiplex PCR 1 (Lanes 1–5) and multiplex PCR 2 (Lanes 6–10) for analysis of various genes. Lanes 1 and 6: V. cholerae O1 (ATCC 11623); lanes 2 and 7: V. cholerae O139 (ATCC 51394); lanes 3 and 8: V. cholerae VCC1969; lanes 4 and 9: V. cholerae VCC2411; lanes 5 and 10: V. cholerae VCC5988; lane M: 100 bp ladder

Multiplex PCR 1 (Lanes 1–5) and multiplex PCR 2 (Lanes 6–10) for analysis of various genes. Lanes 1 and 6: V. cholerae O1 (ATCC 11623); lanes 2 and 7: V. cholerae O139 (ATCC 51394); lanes 3 and 8: V. cholerae VCC1969; lanes 4 and 9: V. cholerae VCC2411; lanes 5 and 10: V. cholerae VCC5988; lane M: 100 bp ladder To identify the biotype of the isolates, VP test, polymyxin B resistant test and rtxC PCR were performed. Results showed that all isolates were VP negative, resistant to polymyxin B and PCR positive for repeat in toxin (RTX) gene C (rtxC). Reference V. cholerae O1 classical (ATCC 11623) strain was PCR negative for RTX gene. Both negative VP test and polymyxin B resistance suggested that Chennai isolates belonged to El Tor biotype. The RTX represents a family of important virulence factors that have disseminated widely among gram-negative bacteria (Coote 1992). The RTX gene cluster in V. cholerae encodes the presumptive cytotoxin (rtxA), an acyltransferase (rtxC), and an associated ATP-binding cassette transporter system (Lin et al. 1999). PCR assays developed for rtxA or rtxC in V. cholerae can differentiate El Tor biotype from classical biotype among O1 serogroup (Chow et al. 2001). The positive amplification of rtxC gene among the isolates further confirmed El Tor biotype. In addition to ctxB and rtxC genes, the isolates were also positive for haemolysin (hlyA), zonula occludens (zot), accessory cholera toxin (ace), toxin coregulated pilus (tcp), outer membrane protein (ompU) and toxR genes. Cholera pathogenesis is a complex process and involves synergetic action of several genes. Although cholera toxin (CT) is supposed to be the most important epidemic marker among various toxins produced by V. cholerae (Kaper et al. 1995), CT is encoded by a mobile element, the genome of a filamentous CTX bacteriophage. The acquisition of CTXϕ relies on the presence of toxin co-regulated pilus (encoded by tcp genes) on cell surface, which acts as a receptor for CTXϕ infection (Waldor and Mekalanos 1996). Zonula occludens toxin (zot) and accessory cholera toxin (ace) genes are, in fact, genes encoding for CTXϕ structural proteins (Waldor and Mekalanos 1996). The simultaneous detection of the suite of ancillary toxin genes with ctxB gene confirmed the presence of CTX prophage in Chennai isolates.

Alteration of ctxB gene among El Tor strains

Figure 2 shows the amino acid sequences deduced from the nucleic acid sequences of ctxB gene. Interestingly, the CTX B sequences from the Chennai outbreak strains aligned with O1 classical reference strains. The deduced amino acid sequences differed from that of the reference El Tor strain by a histidine at position 39 and a threonine at position 68. Thus, the results indicated that Chennai El Tor strains contained an altered cholera toxin gene. It is likely caused by infection by classical CTXΦ. More accurately, Chennai outbreak was caused by a “hybrid” El Tor strain with classical phage. Similar results have been reported earlier from other countries in Asia and Africa (Nair et al. 2006; Safa et al. 2008) and more recently in eastern India (Kumar et al. 2009). The discovery of El Tor strains with classical ctxB gene in Chennai outbreak implied a wide-spread of El Tor strains with the “newly acquired” classical toxin gene in the Indian subcontinent.
Fig. 2

Amino acid sequence alignment of CTX-B subunit of V. cholerae O1 El Tor strains from Chennai outbreak with reference El Tor and classical strains. Identical amino acid residues are indicated by dots. Amino acid sequences of V. cholerae CTX-B reference strains used in alignment were retrieved from GenBank

Amino acid sequence alignment of CTX-B subunit of V. cholerae O1 El Tor strains from Chennai outbreak with reference El Tor and classical strains. Identical amino acid residues are indicated by dots. Amino acid sequences of V. cholerae CTX-B reference strains used in alignment were retrieved from GenBank The seventh and current pandemic of cholera is caused by the El Tor biotype. The classical biotype is believed to be extinct (Nair et al. 2002; Safa et al. 2008). The classical and El Tor biotypes of V. cholerae O1 are closely related in their O-antigen biosynthetic genes. However, the genomic structure of the CTXΦ, in which the cholera toxin genes are contained, differs between the classical and El Tor biotypes (Waldor and Mekalanos 1996; Ansaruzzaman et al. 2004). The results from India and Bangladesh showed that classical CT producing El Tor strains are now replacing the seventh pandemic El Tor strains (Nair et al. 2002, 2006; Kumar et al. 2009). This is taken as an evolutionary optimization of the El Tor biotype, which could represent a new and more significant emerging form of the El Tor biotype of V. cholerae.

Antibiotic resistant and mobile elements

Antibiotic susceptibility test revealed that all 44 isolates were sensitive to ampicillin, ceftazidime, chloramphenicol, ciprofloxacin, gentamicin, kanamycin, norfloxacin and tetracycline. However, the isolates exhibited high rate of resistance towards co-trimoxazole, nalidixic acid, nitrofurantoin, spectinomycin, streptomycin, sulphamethizole, sulphamethoxazole and trimethoprim. All the isolates were resistant to polymyxin-B, a typical feature of El Tor biotype strains. Multiple antibiotic resistance among V. cholerae has emerged as a major problem worldwide (Faruque et al. 2007). In India, there is a progressive increasing trend of antibiotic resistance towards common fluoroquinolone, i.e., ciprofloxacin and norfloxacin since 1996 (Garg et al. 2001; Krishna et al. 2006). In this study, however, strains are sensitive to ciprofloxacin and norfloxacin but resistant to nalidixic acid, a non-fluorinated quinolone. In addition, isolates were sensitive to tetracycline, which is different from reports from other regions of India showing a re-emergence of tetracycling resistant strains (Jesudason 2006). Multi-drug resistance among V. cholerae strains limits the therapeutic potential of these drugs. Some antibiotics are already deemed unsuitable for certain group of population, i.e., tetracycline is not recommended for use in children and quinolone are not recommended in pregnant women and children (Sabeena et al. 2001). Multi-drug resistance presents additional challenges to disease management. PCR results showed positive amplification of class 1 integron from Chennai isolates (Fig. 3). Integrons are an important mechanism for the acquisition of antibiotic resistance genes in many bacteria (Hall and Collis 1995). These elements are not autonomously mobile but are able to capture, integrate and express resistance gene cassettes in their variable region. In this study, isolates were found to have integrons on the basis of PCR with 3′CS conserved sequence. PCR results also confirmed the presence of aadA2 gene cassettes within the integron. The aadA2 gene cassettes encode aminoglycoside adenylyltransferases inactivating streptomycin and spectinomycin (Recchia and Hall 1995). These gene cassettes are among the most prevalent gene cassettes in class 1 and class 2 integrons. All isolates were negative for blaP1, the β-lactam gene cassette, corresponding to the phenotypic sensitivity of Chennai strains to ampicillin and ceftazidime.
Fig. 3

PCR detection of class 1 integron, SXT constin and the associated antibiotic resistance genes. Lanes 1, 3, 5, 7, 9 and 11: Chennai isolate VCC1969; and lanes 2, 4, 6, 8, 10 and 12: Chennai isolate VCC5988. Lane M: 100 bp ladder

PCR detection of class 1 integron, SXT constin and the associated antibiotic resistance genes. Lanes 1, 3, 5, 7, 9 and 11: Chennai isolate VCC1969; and lanes 2, 4, 6, 8, 10 and 12: Chennai isolate VCC5988. Lane M: 100 bp ladder Recent studies suggest SXT constin as an important element for horizontal dissemination of antibiotic resistant genes in bacteria (Beaber and Waldor 2004). In SXT constins, the antibiotic resistance genes are clustered within a composite transposon-like structure found near the 5′ end of SXT. These genes confer resistance to chloramphenicol, sulphamethoxazole, streptomycin and trimethoprim (Beaber et al. 2002). In this study, all strains were found PCR positive for SXT integrase gene suggesting the presence of STX constin (Fig. 3). They were resistant to sulphamethoxazole, streptomycin and trimethoprim but were sensitive to chloramphenicol. The presence of strA gene within SXT was confirmed by PCR, which mediates resistance to streptomycin by phosphotransferase enzymes (aminoglycoside-3′-phosphotransferase and aminoglycoside-6′-phosphotransferase (Shaw et al. 1993). However, all isolates were PCR negative for floR gene, which is responsible for resistance towards chloramphenicol (Fig. 3). The deletion of floR gene within SXT contin suggests evolution of resistance characteristics through mobile element. SXT variants have been reported among clinical V. cholerae isolates in recent years (Faruque et al. 2003; Iwanaga et al. 2004). Early reports indicated the loss of resistance to sulphamethoxazole and trimethoprim, and showed varying resistance to streptomycin (Mukhopadhyay et al. 1998; Faruque et al. 2003). The new SXT variant found in Chennai isolates reconfirmed the importance of mobile element in the development of antibiotic resistance. We have demonstrated a direct correlation between the antibiotic resistant phenotype and the presence of drug resistance genes in Class 1 integron and SXT constins among Chennai isolates.

DNA fingerprinting analyses

All 44 V. cholerae isolates were characterized by ERIC- and BOX PCR to reveal the clonal relationship. ERIC PCR with genomic DNA of V. cholerae strains resulted in amplification of multiple fragments of DNA ranging between 0.25 and 1.8 kb. The BOX PCR of genomic DNA resulted in fragments varying between 0.65 and 6.0 kb. The fingerprinting analysis revealed identical DNA banding pattern among all 44 isolates, suggesting that a single clone of V. cholerae likely caused the Chennai outbreak over the 7-month period. In summary, the study demonstrated that V. cholerae O1 El Tor biotype was responsible for the seven-month Chennai outbreak in 2004. This El Tor strain, however, contained classical cholera toxin gene, suggesting infection of isolates by classical CTXΦ. Mobile elements in the strain conferred multiple antibiotic resistances. All the isolates were derived from a single clone that initiated the outbreak in the area. This study calls attention for continuous monitoring of outbreak strains to understand the evolution of pathogen and disease pattern. Below is the link to the electronic supplementary material. DOCX 251 kb
  35 in total

1.  Emergence of fluoroquinolone-resistant strains of Vibrio cholerae O1 biotype El Tor among hospitalized patients with cholera in Calcutta, India.

Authors:  P Garg; S Sinha; R Chakraborty; S K Bhattacharya; G B Nair; T Ramamurthy; Y Takeda
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  Fluoroquinolone-resistant Vibrio cholerae isolated during a cholera outbreak in India.

Authors:  B V S Krishna; Asha B Patil; M R Chandrasekhar
Journal:  Trans R Soc Trop Med Hyg       Date:  2005-10-24       Impact factor: 2.184

3.  Cholera due to altered El Tor strains of Vibrio cholerae O1 in Bangladesh.

Authors:  G Balakrish Nair; Firdausi Qadri; Jan Holmgren; Ann-Mari Svennerholm; Ashrafus Safa; Nurul A Bhuiyan; Q Shafi Ahmad; Shah M Faruque; A S G Faruque; Yoshifumi Takeda; David A Sack
Journal:  J Clin Microbiol       Date:  2006-09-06       Impact factor: 5.948

4.  Detection of RTX toxin gene in Vibrio cholerae by PCR.

Authors:  K H Chow; T K Ng; K Y Yuen; W C Yam
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

5.  Single multiplex polymerase chain reaction for environmental surveillance of toxigenic-pathogenic O1 and non-O1 Vibrio cholerae.

Authors:  A K Goel; S Ponmariappan; D V Kamboj; L Singh
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.099

6.  Plasmid evolution by acquisition of mobile gene cassettes: plasmid pIE723 contains the aadB gene cassette precisely inserted at a secondary site in the incQ plasmid RSF1010.

Authors:  G D Recchia; R M Hall
Journal:  Mol Microbiol       Date:  1995-01       Impact factor: 3.501

7.  Dissemination of a single Vibrio cholerae clone in cholera outbreaks during 2005 in Iran.

Authors:  M R Pourshafie; B Bakhshi; R Ranjbar; M Sedaghat; N Sadeghifard; J Zaemi Yazdi; M Parzadeh; J Raesi
Journal:  J Med Microbiol       Date:  2007-12       Impact factor: 2.472

Review 8.  Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes.

Authors:  K J Shaw; P N Rather; R S Hare; G H Miller
Journal:  Microbiol Rev       Date:  1993-03

9.  Site-specific deletion and rearrangement of integron insert genes catalyzed by the integron DNA integrase.

Authors:  C M Collis; R M Hall
Journal:  J Bacteriol       Date:  1992-03       Impact factor: 3.490

10.  Enterobacterial repetitive intergenic consensus sequences and the PCR to generate fingerprints of genomic DNAs from Vibrio cholerae O1, O139, and non-O1 strains.

Authors:  I G Rivera; M A Chowdhury; A Huq; D Jacobs; M T Martins; R R Colwell
Journal:  Appl Environ Microbiol       Date:  1995-08       Impact factor: 4.792

View more
  18 in total

1.  Cholera epidemic in and around kolkata, India: endemicity and management.

Authors:  Shyamapada Mandal
Journal:  Oman Med J       Date:  2011-07

2.  Phenotypic and genetic characterization of Vibrio cholerae O1 clinical isolates collected through national antimicrobial resistance surveillance network in Nepal.

Authors:  Geeta Shakya; Dong Wook Kim; John D Clemens; Sarala Malla; Bishnu Prasad Upadhyaya; Shyam Prakash Dumre; Sirjana Devi Shrestha; Shailaja Adhikari; Supriya Sharma; Nisha Rijal; Sanjaya K Shrestha; Carl Mason; Palpasa Kansakar
Journal:  World J Microbiol Biotechnol       Date:  2012-05-23       Impact factor: 3.312

3.  Electrochemical genosensor for specific detection of the food-borne pathogen, Vibrio cholerae.

Authors:  Kim-Fatt Low; Kritsanaporn Chuenrangsikul; Patsamon Rijiravanich; Werasak Surareungchai; Yean-Yean Chan
Journal:  World J Microbiol Biotechnol       Date:  2011-12-18       Impact factor: 3.312

4.  Molecular characterization reveals involvement of altered El Tor biotype Vibrio cholerae O1 strains in cholera outbreak at Hyderabad, India.

Authors:  Ajay Kumar Goel; Meenu Jain; Pramod Kumar; Pennagaram Sarguna; Meera Bai; Neha Ghosh; Natrajan Gopalan
Journal:  J Microbiol       Date:  2011-05-03       Impact factor: 3.422

5.  Molecular Characterization of Vibrio cholerae O1 Reveals Continuous Evolution of Its New Variants in India.

Authors:  M Jain; K S Kushwah; P Kumar; A K Goel
Journal:  Indian J Microbiol       Date:  2013-02-12       Impact factor: 2.461

6.  Vibrio cholerae Porin OmpU Induces Caspase-independent Programmed Cell Death upon Translocation to the Host Cell Mitochondria.

Authors:  Shelly Gupta; G V R Krishna Prasad; Arunika Mukhopadhaya
Journal:  J Biol Chem       Date:  2015-11-11       Impact factor: 5.157

7.  Multi-drug resistant Vibrio cholerae O1 variant El Tor isolated in northern Vietnam between 2007 and 2010.

Authors:  Huu Dat Tran; Munirul Alam; Nguyen Vu Trung; Nguyen Van Kinh; Hong Ha Nguyen; Van Ca Pham; Mohammad Ansaruzzaman; Shah Manzur Rashed; Nurul A Bhuiyan; Tuyet Trinh Dao; Hubert P Endtz; Heiman F L Wertheim
Journal:  J Med Microbiol       Date:  2011-10-20       Impact factor: 2.472

8.  Association of Heavy Rainfall on Genotypic Diversity in V. cholerae Isolates from an Outbreak in India.

Authors:  A K Goel; S C Jiang
Journal:  Int J Microbiol       Date:  2011-12-12

9.  Molecular Characterization of Vibrio cholerae Isolated From Clinical Samples in Kurdistan Province, Iran.

Authors:  Rashid Ramazanzadeh; Samaneh Rouhi; Pegah Shakib; Babak Shahbazi; Farzam Bidarpour; Mohammad Karimi
Journal:  Jundishapur J Microbiol       Date:  2015-05-31       Impact factor: 0.747

10.  Vibrio cholerae porin OmpU induces pro-inflammatory responses, but down-regulates LPS-mediated effects in RAW 264.7, THP-1 and human PBMCs.

Authors:  Sanica C Sakharwade; Praveen K Sharma; Arunika Mukhopadhaya
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.